Skip to main content
Signal8

Wadhane Jitendra

SEC insider (Form 3/4/5 filer). CIK 0001941706. Prin Fin & Acct Officer at Pyxis Oncology, Inc. (PYXS). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 24, 2026. Located in BOSTON, MA.

Companies Wadhane Jitendra has filed insider reports for

  • Pyxis Oncology, Inc. (PYXS): Officer, Prin Fin & Acct Officer
Wadhane Jitendra profile photo

Wadhane Jitendra

CIK: 0001941706

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Pyxis Oncology, Inc. logo
PYXS

Pyxis Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Mar 24, 2026
    Award
    Direct
    109.5K shares-
  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Mar 31, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    263.8K shares at avg. $0.98-
  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Dec 23, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    150K shares-

1-3 of 3